Barely Significant
← all excerpts

<i>KRAS</i>, <i>NRAS</i>, and <i>BRAF</i> mutations in plasma cell myeloma at a single Korean institute.

Blood Res · 2020 · PMC7536562 · PMID 32989177

Europe PMCDOI
1
hedged sentence
0.0810
closest p · 1.6× alpha
0.0810
boldest claim

The sentences

a statistical trendP =0.081so close (0.05 < p ≤ 0.1)
Patients with RAS mutations, presented in either KRAS and NRAS (N=8), showed a statistical trend of poor median PFS compared to those without RAS mutations (N=42) [16.3 mo (95% CI, 0.4–26) vs. 23.9 mo (95% CI, 17.6–29), P =0.081, Fig. 2D ].

also in 2,798 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.